SCHEMBL8338348

SCHEMBL8338348

CNC(=S)NC(=O)C(CCCN=S(=O)=O)c1ccc(OC)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.39
▸ GPR88 Q9GZN0 1/20 0.38
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MMP1 P03956 2/20 0.34
▸ MMP9 P14780 2/20 0.34
▸ MMP13 P45452 2/20 0.34
▸ ADAM17 P78536 2/20 0.34
▸ CNR2 P34972 2/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339477 0.89 GPR88 (0.40) GPR88HDAC1HDAC7CYP1A2CYP3A4
SCHEMBL8339028 0.88 GAA (0.33) TDP1KDM4ELMNACNR2CNR1
SCHEMBL8337813 0.83 TDP1 (0.39) TDP1GPR88HDAC1HDAC7CYP1A2
SCHEMBL8336209 0.81 GPR88 (0.35) TDP1GPR88HDAC1HDAC7MMP1
SCHEMBL8341296 0.81 TDP1 (0.40) TDP1CYP1A2CYP3A4CYP2C9PKM
SCHEMBL8338140 0.81 MMP9 (0.38) TDP1CYP1A2CYP3A4CYP2C9PKM
SCHEMBL8338089 0.80 TDP1 (0.37) TDP1GPR88CYP1A2CYP3A4CYP2C9
SCHEMBL8338207 0.80 TDP1 (0.37) TDP1HDAC1HDAC7CYP1A2CYP3A4
SCHEMBL8334670 0.80 MMP9 (0.41) TDP1HDAC1HDAC7CYP1A2CYP3A4
SCHEMBL8340209 0.79 ADAM17 (0.36) TDP1GPR88HDAC1HDAC7HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback